119 related articles for article (PubMed ID: 37985362)
21. Recurrence after sentinel lymph node biopsy in cutaneous melanoma: a single-center experience in Slovak patients.
Sabol M; Reken V; Sabolova L; Waczulikova I; Donat R; Dyttert D; Chvalny P; Durdik S
Neoplasma; 2019 Jul; 66(4):647-651. PubMed ID: 31058535
[TBL] [Abstract][Full Text] [Related]
22. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.
Bilimoria KY; Balch CM; Bentrem DJ; Talamonti MS; Ko CY; Lange JR; Winchester DP; Wayne JD
Ann Surg Oncol; 2008 Jun; 15(6):1566-76. PubMed ID: 18414952
[TBL] [Abstract][Full Text] [Related]
23. Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.
Beasley GM; Hu Y; Youngwirth L; Scheri RP; Salama AK; Rossfeld K; Gardezi S; Agnese DM; Howard JH; Tyler DS; Slingluff CL; Terando AM
Ann Surg Oncol; 2017 Sep; 24(9):2728-2733. PubMed ID: 28508145
[TBL] [Abstract][Full Text] [Related]
24. Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Voit CA; Stepniak J; Erler NS; Eggermont AM; Wouters MW; Grünhagen DJ; Verhoef CK
Eur J Cancer; 2016 Nov; 67():164-173. PubMed ID: 27669503
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy for melanoma: indications and rationale.
Phan GQ; Messina JL; Sondak VK; Zager JS
Cancer Control; 2009 Jul; 16(3):234-9. PubMed ID: 19556963
[TBL] [Abstract][Full Text] [Related]
26. Sentinel Lymph Node Biopsy Positivity in Patients With Acral Lentiginous and Other Subtypes of Cutaneous Melanoma.
Cheraghlou S; Ugwu N; Girardi M
JAMA Dermatol; 2022 Jan; 158(1):51-58. PubMed ID: 34878492
[TBL] [Abstract][Full Text] [Related]
27. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
28. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
[TBL] [Abstract][Full Text] [Related]
29. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.
Wagner JD; Gordon MS; Chuang TY; Coleman JJ; Hayes JT; Jung SH; Love C
Cancer; 2000 Jul; 89(2):453-62. PubMed ID: 10918179
[TBL] [Abstract][Full Text] [Related]
30. Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery.
MacArthur KM; Baumann BC; Sobanko JF; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; McMurray SL; Krausz A; Newman JG; Rajasekaran K; Cannady SB; Brody RM; Karakousis GC; Miura JT; Cohen JV; Amaravadi RK; Mitchell TC; Schuchter LM; Miller CJ
Cancer; 2021 Oct; 127(19):3591-3598. PubMed ID: 34292585
[TBL] [Abstract][Full Text] [Related]
31. Higher rates of regional disease but improved outcomes in pediatric versus adult melanoma.
Lautz TB; Fahy AS; Helenowski I; Wayne JD; Baertschiger RM; Aldrink JH
J Pediatr Surg; 2022 Oct; 57(10):425-429. PubMed ID: 34872730
[TBL] [Abstract][Full Text] [Related]
32. Development and Validation of a Modified Pathologic Nodal Classification System for Cutaneous Melanoma.
Nguyen AT; Luu M; Nguyen VP; Hamid O; Faries MB; Gharavi NM; Lu DJ; Mallen-St Clair J; Ho AS; Zumsteg ZS
JAMA Surg; 2021 Nov; 156(11):e214298. PubMed ID: 34468697
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
; Crystal JS; Thompson JF; Hyngstrom J; Caracò C; Zager JS; Jahkola T; Bowles TL; Pennacchioli E; Beitsch PD; Hoekstra HJ; Moncrieff M; Ingvar C; van Akkooi A; Sabel MS; Levine EA; Agnese D; Henderson M; Dummer R; Neves RI; Rossi CR; Kane JM; Trocha S; Wright F; Byrd DR; Matter M; Hsueh EC; MacKenzie-Ross A; Kelley M; Terheyden P; Huston TL; Wayne JD; Neuman H; Smithers BM; Ariyan CE; Desai D; Gershenwald JE; Schneebaum S; Gesierich A; Jacobs LK; Lewis JM; McMasters KM; O'Donoghue C; van der Westhuizen A; Sardi A; Barth R; Barone R; McKinnon JG; Slingluff CL; Farma JM; Schultz E; Scheri RP; Vidal-Sicart S; Molina M; Testori AAE; Foshag LJ; Van Kreuningen L; Wang HJ; Sim MS; Scolyer RA; Elashoff DE; Cochran AJ; Faries MB
JAMA Surg; 2022 Sep; 157(9):835-842. PubMed ID: 35921122
[TBL] [Abstract][Full Text] [Related]
34. Patients with sentinel lymph node positive melanoma: Who needs completion lymph node dissection?
Schuitevoerder D; Bubic I; Fortino J; Massimino KP; Vetto JT
Am J Surg; 2018 May; 215(5):868-872. PubMed ID: 29397888
[TBL] [Abstract][Full Text] [Related]
35. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP
Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728
[TBL] [Abstract][Full Text] [Related]
36. Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: Reliability of the procedure and analysis of failures after long-term follow-up.
Jacobs IA; Chevinsky AH; Swayne LC; Magidson JG; Britto EJ; Smith TJ
J Surg Oncol; 2001 Jul; 77(3):157-64. PubMed ID: 11455551
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of nodal patterns for melanoma of the ear.
Cole MD; Jakowatz J; Evans GR
Plast Reconstr Surg; 2003 Jul; 112(1):50-6. PubMed ID: 12832876
[TBL] [Abstract][Full Text] [Related]
38. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
Sinnamon AJ; Song Y; Sharon CE; Yang YX; Elder DE; Zhang PJ; Xu X; Roses RE; Kelz RR; Fraker DL; Karakousis GC
Ann Surg Oncol; 2018 Nov; 25(12):3469-3475. PubMed ID: 30043316
[TBL] [Abstract][Full Text] [Related]
39. Effect of delay between nuclear medicine scanning and sentinel node biopsy on outcome in patients with cutaneous melanoma.
Moncrieff MD; O'Leary FM; Beadsmoore CJ; Pawaroo D; Heaton MJ; Isaksson K; Olofsson Bagge R
Br J Surg; 2020 May; 107(6):669-676. PubMed ID: 32077090
[TBL] [Abstract][Full Text] [Related]
40. Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsy.
Rubinstein JC; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
Cancer Med; 2016 Oct; 5(10):2832-2840. PubMed ID: 27671840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
